(Q63859562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Xueying Sun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Bing Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shangha Pan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Xuesong Dong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Haiquan Qiao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Geoffrey W Krissansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

675-681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Antitumor effect of arsenic trioxide in murine xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Effect of arsenic trioxide on human hepatocarcinoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Myocardial toxicity of arsenic trioxide in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic stimulates angiogenesis and tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

p300 does not require its acetylase activity to stimulate p73 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00230.X

10.1111/J.1349-7006.2006.00230.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827809%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference